» Articles » PMID: 35895480

Composition of Naturally Occurring Compounds Decreases Activity of Omicron and SARS-CoV-2 RdRp Complex

Overview
Publisher Akademiai Kiado
Date 2022 Jul 27
PMID 35895480
Authors
Affiliations
Soon will be listed here.
Abstract

Naturally-occurring compounds are acknowledged for their broad antiviral efficacy. Little is however known about their mutual cooperation. Here, we evaluated in vitro efficacy of the defined mixture of agents against the RdRp complex of the original SARS-CoV-2 and Omicron variant. This composition of vitamin C, N-acetylcysteine, resveratrol, theaflavin, curcumin, quercetin, naringenin, baicalin, and broccoli extract showed to inhibit activity of RdRp/nsp7/nsp8 both these variants. In vitro exposure of recombinant RdRp complex to individual compounds of this composition pointed to quercetin as the driving inhibitory compound. The outcome of this study supports the motion of antiviral efficacy of natural compounds against SARS-CoV-2 and Omicron and implies that their reciprocal or mutual interaction may augment antiviral action through simultaneous effect on different mechanisms. Consequently, this makes it more difficult for an infectious agent to evade all these mechanisms at the same time. Considering the urgency in finding effective prevention, but also side-effects free treatment of COVID-19 our results call for clinical affirmation of the benefits of this micronutrient combination in both preventive and therapeutic aspects. Whether observed effects can be achieved, by concentrations of the active agents used in these in vitro experiments, in in vivo or clinical setting warrants further study.

Citing Articles

The Inhibiting Effect of GB-2, (+)-Catechin, Theaflavin, and Theaflavin 3-Gallate on Interaction between ACE2 and SARS-CoV-2 EG.5.1 and HV.1 Variants.

Lu C, Lung J, Shu L, Liu H, Wu Y, Lin Y Int J Mol Sci. 2024; 25(17).

PMID: 39273444 PMC: 11394907. DOI: 10.3390/ijms25179498.


Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.

Comunale B, Larson R, Hsu Y, Jackson-Ward E, Azodoh C, Singh A Vaccines (Basel). 2024; 12(3).

PMID: 38543853 PMC: 10974902. DOI: 10.3390/vaccines12030219.


The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic.

Comunale B, Larson R, Jackson-Ward E, Singh A, Koback F, Engineer L Viruses. 2023; 15(12).

PMID: 38140557 PMC: 10747147. DOI: 10.3390/v15122316.


Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.

Kumar A, Dutt M, Dehury B, Martinez G, Swan C, Kelvin A J Biomol Struct Dyn. 2023; 43(2):1068-1082.

PMID: 38115191 PMC: 11716671. DOI: 10.1080/07391102.2023.2291165.


Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Wang Z, Song X, Xu W, Lei S, Zhang H, Yang L Nutrients. 2023; 15(18).

PMID: 37764669 PMC: 10535599. DOI: 10.3390/nu15183885.


References
1.
Liu F, Zhu Y, Zhang J, Li Y, Peng Z . Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. 2020; 10(7):e039519. PMC: 7348463. DOI: 10.1136/bmjopen-2020-039519. View

2.
Vkovski P, Kratzel A, Steiner S, Stalder H, Thiel V . Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2020; 19(3):155-170. PMC: 7592455. DOI: 10.1038/s41579-020-00468-6. View

3.
Venkateshan M, Muthu M, Suresh J, Kumar R . Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis. J Mol Struct. 2020; 1220:128741. PMC: 7309803. DOI: 10.1016/j.molstruc.2020.128741. View

4.
Goc A, Sumera W, Rath M, Niedzwiecki A . Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. PLoS One. 2021; 16(6):e0253489. PMC: 8211150. DOI: 10.1371/journal.pone.0253489. View

5.
Jiang Y, Yin W, Xu H . RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Biochem Biophys Res Commun. 2020; 538:47-53. PMC: 7473028. DOI: 10.1016/j.bbrc.2020.08.116. View